Related Experiment Video
Updated: Jul 16, 2026
14:40
Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings
Published on: October 25, 2015
Taurine as a marker for foetal wellbeing?
Hendrina A de Boo1, Jane E Harding
1The Liggins Institute, University of Auckland, Auckland, New Zealand. n.deboo@auckland.ac.nz
Neonatology
|March 23, 2007
Summary
Elevated fetal taurine concentrations indicate compromised wellbeing in sheep fetuses following placental embolization. Higher taurine levels correlated with increased morbidity and mortality, suggesting taurine
Area of Science:
- Perinatal medicine
- Fetal physiology
- Maternal-fetal interface
Background:
- Placental embolization in pregnant sheep led to elevated fetal plasma taurine.
- These fetuses exhibited higher morbidity and mortality compared to those with normal taurine levels.
- Study subgroups were defined as elevated taurine (EH) and low taurine (EL) concentrations.
Purpose of the Study:
- To investigate fetal plasma taurine concentration as a potential marker for fetal wellbeing.
- To understand the role of taurine in fetal adaptation to placental insufficiency.
Main Methods:
- Measurement of growth, metabolic, and endocrine parameters in fetal sheep.
- Comparison between normally grown fetuses and those with EH or EL after placental embolization.
Main Results:
- EH fetuses showed reduced weight, hind limb length, and growth rate (chest girth increment).
- EH fetuses experienced hypoxemia, hypoglycemia, and increased lactate.
- EH fetuses had increased kidney, liver, and adrenal weights, and decreased thymus weight.
Conclusions:
- Fetuses with EH were less able to compensate for placental embolization effects.
- Taurine release may be a protective mechanism against hypoxia-induced inflammation or for osmotic balance.
- Further research is warranted to explore the link between taurine and fetal wellbeing.
Related Concept Videos
01:14Fetal Circulation
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...